A FinnGen pilot clinical recall study for Alzheimer’s disease

Successful development of novel therapies requires that clinical trials are conducted in patient cohorts with the highest benefit-to-risk ratio. Population-based biobanks with comprehensive health and genetic data from large numbers of individuals hold promise to facilitate identification of trial p...

Descripción completa

Detalles Bibliográficos
Autores principales: Julkunen, Valtteri, Schwarz, Claudia, Kalapudas, Juho, Hallikainen, Merja, Piironen, Aino-Kaisa, Mannermaa, Arto, Kujala, Hanna, Laitinen, Timo, Kosma, Veli-Matti, Paajanen, Teemu I., Kälviäinen, Reetta, Hiltunen, Mikko, Herukka, Sanna-Kaisa, Kärkkäinen, Sari, Kokkola, Tarja, Urjansson, Mia, Perola, Markus, Palotie, Aarno, Vuoksimaa, Eero, Runz, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400697/
https://www.ncbi.nlm.nih.gov/pubmed/37537264
http://dx.doi.org/10.1038/s41598-023-39835-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400697/
https://www.ncbi.nlm.nih.gov/pubmed/37537264
http://dx.doi.org/10.1038/s41598-023-39835-7

Ejemplares similares